Skip to main content

Astrazeneca: Coronavirus

Question for Department for Business, Energy and Industrial Strategy

UIN 104731, tabled on 16 October 2020

To ask the Secretary of State for Business, Energy and Industrial Strategy, what assessment he has made of (a) when the not for profit price commitment made by AstraZeneca as part of the deal with Oxford University to develop a covid-19 vaccine will expire and (b) the effect of the expiration of that commitment on the affordability of that vaccine for the NHS.

This answer is the replacement for a previous holding answer.

Answered on

22 October 2020

The timings of the not for profit price commitment are for the two parties involved, AstraZeneca and the University of Oxford to agree.

The NHS is preparing for the initial deployment of a safe, effective COVID-19 vaccine as soon as possible.

Answered by

Department for Business, Energy and Industrial Strategy
Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.